Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTICANCER EFFECT ENHANCER
Document Type and Number:
Japanese Patent JP2011144190
Kind Code:
A
Abstract:

To provide an agent for enhancing an effect of an anticancer agent for achieving an excellent therapeutic effect on cancer.

The agent for enhancing an effect of an anticancer agent comprises a nitric oxide donor, particularly isosorbide dinitrate as an active ingredient and is used in combination with a platinum preparation as an anticancer agent. An excellent therapeutic effect can be achieved on non-small cell lung carcinoma which is in such a state that no effective therapeutic method is established for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.


More Like This:
WO/1993/003719ARYLALKYLETHER AND ARYLALKYLTHIOETHER INHIBITORS OF LIPOXYGENASE ENZYME ACTIVITY
JPH02240059CYCLOAMINOALKOXYPHENYL DERIVATIVE, PREPARATION THEREOF, AND COMPOSITION CONTAINING THE SAME
JPH05509078[Title of Invention] Growth Inhibitor and Cancer and Cell Proliferative Disease Control Law
Inventors:
YASUDA HIROYASU
YAMATANI MUTSUO
NAKAYAMA KATSUTOSHI
SASAKI HIDETADA
Application Number:
JP2011047781A
Publication Date:
July 28, 2011
Filing Date:
March 04, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NIPPON KAYAKU KK
International Classes:
A61K31/34; A61K33/24; A61P35/00; A61P43/00
Domestic Patent References:
JP2000506133A2000-05-23
Foreign References:
WO1995010267A11995-04-20
WO2003074082A12003-09-12
Other References:
JPN6013005464; ＹＡＮＯ，　Ｓ．　ｅｔ　ａｌ．: Ｊａｐａｎｅａｓｅ　Ｃｉｒｃｕｌａｔｉｏｎ　Ｊｏｕｒｎａｌ Ｖｏｌ．６０, 1996, ｐ．１８５-１８８
Attorney, Agent or Firm:
Yuji Tsujida
Yoshihiro Shimizu
Shinichi Abe



 
Previous Patent: LIGAND FOR METABOTROPIC GLUTAMATE RECEPTOR AND INHIBITOR OF NAALADase

Next Patent: ANTI-CD19 ANTIBODY